A bioluminescent assay for monoamine oxidase activity

Analytical Biochemistry

Volumn 359, Issue 2, 2006, Pages 238-246

  Valley, Michael P ^a   Zhou, Wenhui ^b   Hawkins, Erika M ^a   Shultz, John ^a   Cali, James J ^a   Worzella, Tracy ^a   Bernad, Laurent ^b   Good, Troy ^b   Good, Dave ^b   Riss, Terry L ^a   Klaubert, Dieter H ^b   Wood, Keith V ^a  

^a PROMEGA CORPORATION   (United States)

^b Promega Biosciences   (United States)

Author keywords

Bioluminescence; Bioluminescent monoamine oxidase assay; Drug metabolism; Luciferase; Screening assays

Indexed keywords

FLUORESCENCE; METABOLISM;

BIOLUMINESCENT ASSAY; DRUG METABOLISMS; FLUORESCENT METHODS; HIGH THROUGHPUT SCREENING; LUCIFERASE; MONOAMINE OXIDASE; PHARMACOLOGICALLY ACTIVE COMPOUNDS; SCREENING ASSAYS;

BIOLUMINESCENCE;

AMINE OXIDASE (FLAVIN CONTAINING); LUCIFERIN; MONOAMINE OXIDASE INHIBITOR;

ACCURACY; ARTICLE; BINDING AFFINITY; BIOLUMINESCENCE; CHEMOLUMINESCENCE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INACTIVATION; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME STABILITY; FLUORESCENCE; HALF LIFE TIME; HIGH THROUGHPUT SCREENING; INCUBATION TIME; LIGHT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

EID: 33751411145     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.09.035     Document Type: Article

References (29)

1. Edmondson D.E., Mattevi A., Binda C., Li M., and Hubalek F. Structure and mechanism of monoamine oxidase. Curr. Med. Chem. 11 (2004) 1983-1993
2. Bach A.W., Lan N.C., Johnson D.L., Abell C.W., Bembenek M.E., Kwan S.W., Seeburg P.H., and Shih J.C. cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. USA 85 (1988) 4934-4938
3. Benedetti M.S. Biotransformation of xenobiotics by amine oxidases. Fundam. Clin. Pharmacol. 15 (2001) 75-84
4. Shih J.C., Chen K., and Ridd M.J. Monoamine oxidase: from genes to behavior. Annu. Rev. Neurosci. 22 (1999) 197-217
5. Toninello A., Pietrangeli P., De Marchi U., Salvi M., and Mondovi B. Amine oxidases in apoptosis and cancer. Biochim. Biophys. Acta 1765 (2006) 1-13
6. Gnerre C., Kosel M., Baumann P., Carrupt P.A., and Testa B. Interaction of psychotropic drugs with monoamine oxidase in rat brain. J. Pharm. Pharmacol. 53 (2001) 1125-1130
7. Dams R., Benijts T.H., Lambert W.E., Van Bocxlaer J.F., Van Varenbergh D., Van Peteghem C., and De Leenheer A.P. A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication. J. Anal. Toxicol. 25 (2001) 147-151
8. Carter A.R., Zhou Z.H., Calhoun D.A., and Bubien J.K. Hyperactive ENaC identifies hypertensive individuals amenable to amiloride therapy. Am. J. Physiol. Cell Physiol. 281 (2001) C1413-C1421
9. Duff H.J., Mitchell L.B., Kavanagh K.M., Manyari D.E., Gillis A.M., and Wyse D.G. Antiarrhythmic and electrophysiologic actions in patients with inducible sustained ventricular tachycardia. Circulation 79 (1989) 1257-1263
10. Palaty V., and Cragoe Jr. E.J. Inhibition of monoamine oxidase by analogues of amiloride. Mol. Pharmacol. 36 (1989) 296-301
11. Zubieta J.K., Cragoe Jr. E.J., and Cubeddu L.X. Effects of amiloride and 5-(N,N-hexamethylene)amiloride on dopaminergic and cholinergic neurotransmission. J. Pharmacol. Exp. Ther. 247 (1988) 88-95
12. In: Wade A. (Ed). Martindale: The Extra Pharmacopoeia. twentyseveth ed. (1977), Pharmaceutical Press, London
13. Kalgutkar A.S., Dalvie D.K., O'Donnell J.P., Taylor T.J., and Sahakian D.C. On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics. Curr. Drug Metab. 3 (2002) 379-424
14. Kalgutkar A.S., Dalvie D.K., Castagnoli Jr. N., and Taylor T.J. Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors. Chem. Res. Toxicol. 14 (2001) 1139-1162
15. Benedetti M.S., and Dostert P. Contribution of amine oxidases to the metabolism of xenobiotics. Drug Metab. Rev. 26 (1994) 507-535
16. Holt A., Sharman D.F., Baker G.B., and Palcic M.M. A continuous spectrophotometric assay form monoamine oxidase and related enzymes in tissue homogenates. Anal. Biochem. 244 (1997) 384-392
17. Zhou M., and Voloshina N.P. A one-step fluorometric method for the continuous measurement of monoamine oxidase activity. Anal. Biochem. 253 (1997) 169-174
18. Zhou W., Valley M.P., Shultz J., Hawkins E.M., Bernad L., Good T., Good D., Riss T.L., Klaubert D.H., and Wood K.V. New bioluminogenic substrates for monoamine oxidase assays. J. Am. Chem. Soc. 128 (2006) 3122-3123
19. Schoepp D.D., and Azzaro A.J. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum. J. Neurochem. 36 (1981) 2025-2031
20. Tsugeno Y., Hirashiki I., Ogata F., and Ito A. Regions of the molecule responsible for substrate specificity of monoamine oxidase A and B: A chimeric enzyme analysis. J. Biochem. (Tokyo) 118 (1995) 974-980
21. Zhang J.H., Chung T.D., and Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen 4 (1999) 67-73
22. Suzuki O., Katsumata Y., and Oya M. Oxidation of β-phenylethylamine by both types of monoamine oxidase: Examination of enzymes in brain and liver mitochondria of eight species. J. Neurochem. 36 (1981) 1298-1301
23. Reszka K.J., Wagner B.A., Burns C.P., and Britigan B.E. Effects of peroxidase substrates on the Amplex Red/peroxidase assay: Antioxidant properties of anthracyclines. Anal. Biochem. 342 (2005) 327-337
24. Zhou M., Diwu Z., Voloshina N.P., and Haugland R.P. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: Applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal. Biochem. 253 (1997) 162-168
25. O'Brien M.A., Daily W.J., Hesselberth P.E., Moravec R.A., Scurria M.A., Klaubert D.H., Bulleit R.F., and Wood K.V. Homogeneous, bioluminescent protease assays. J. Biomol. Screen. 10 (2005) 137-148
26. Grant S.K., Sklar J.G., and Cummings R.T. Development of novel assays for proteolytic enzymes using rhodamine-based fluorogenic substrates. J. Biomol. Screen. 7 (2002) 531-540
27. Johnston J.P. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmacol. 17 (1968) 1285-1297
28. Tipton K.F., Fowler C.J., and Houslay M.D. Specificities of the two forms of monoamine oxidase. In: Kamijo K., Usdin E., and Nagatsu T. (Eds). Monoamine Oxidase: Basic and Clinical Frontiers (1982), Excerpta Medica, Amsterdam 87-99
29. Geha R.M., Rebrin I., Chen K., and Shih J.C. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid. J. Biol. Chem. 276 (2001) 9877-9882